Strolll
Stafford, United KingdomSee on the mapFounded 2019
- Neurorehabilitation and assistive tech
- Series A
Strolll develops augmented reality technology for neurological rehabilitation, bringing visual cues, movement, and progression into patients’ real-world environments. Its platform is designed to make therapy more engaging and support clinicians in delivering high-intensity rehabilitation that fits clinical workflows.
- Open roles
- 1
- RaisedTotal raised
- $47.2M
- Mar 2025Latest priced round, Mar 2025
- Series A
- Investors
- 12
- Founded
- 2019
reccy insights
Strolll’s most recent recorded financing activity was on Sep 3, 2026, when it announced a $1.35 million venture round led by IW Capital, alongside a $4.87 million debt financing and a $946,933 grant. Additional financing entries dated the same day include $4.15 million in conventional debt and a $7.34 million grant, although the available details do not clarify how these relate to the other September transactions. In 2025, the company raised a $13.40 million Series A dated Mar 11, 2025, with IW Capital listed as lead investor; Cleveland Clinic and Kluz Ventures also appear among the round’s investors. Earlier milestones include a $3 million corporate round on Aug 20, 2024, involving Cleveland Clinic and IW Capital, and a $2.56 million seed round dated Oct 17, 2023. Strolll’s Reality DTx product applies augmented reality to gait-and-balance rehabilitation for people with Parkinson’s disease and other neurological conditions.
Written by reccy's AI from company sites, press and funding records · updated Nov 2026
Open roles1
What makes Strolll distinct
- 01Projects visual gait cues into a patient’s real-world field of view using augmented-reality glasses.
- 02Combines cueing with gamified exercises and therapy progression for gait-and-balance rehabilitation.
- 03Supports clinicians in prescribing, tailoring, and remotely monitoring home-based programs.
- 04Focuses on Parkinson’s disease and other neurological conditions associated with fall risk.
Technology & products
- Reality DTx
An augmented-reality digital therapeutic for gait-and-balance neurorehabilitation. It delivers visual cues and gamified exercises through see-through AR glasses and supports clinician prescription, tailored programs, and remote monitoring.
- Reality DTx, an augmented-reality digital therapeutic for neurorehabilitation.
- See-through AR glasses that display cueing lines and exercises in the patient’s real environment.
- Digital visual cueing integrated with movement exercises and therapy progression.
- Clinician-oriented tools for program tailoring and remote monitoring.
Research roots1
Labs and research groups this company came from or works with.
- No page yetVrije Universiteit AmsterdamAmsterdam, NetherlandsAmsterdam, Netherlands · No page yetOther link
Funding
- DebtSep 2026$4.9MLed by Innovate UK
- Venture RoundSep 2026$1.4MLed by IW Capital, Cleveland Clinic, Future Planet Capital
- GrantSep 2026$947KLed by UK Research and Innovation, Innovate UK
Investors11
- IW Capital
- Kluz Ventures
- Propel@YH
- Midven
Similar companies
About Strolll
- Products
- Reality DTx
- Leadership
- Rupert BarksfieldTom FinnJorgen Ellis
- Focus areas
- Digital Health, augmented reality, neurorehabilitation, healthcare, physical therapy, clinical workflow, parkinsonism, B2B
- Headquarters
- Stafford, United Kingdom
- Founded
- 2019
- Employees
- 11–50
- Status
- Active · private